Godavari Drugs
121.00
-1.90(-1.55%)
Market Cap₹122.58 Cr
PE Ratio30.42
IndustryHealthcare
Company Performance:
1D-1.55%
1M+0.04%
6M+37.16%
1Y+37.03%
5Y+55.83%
View Company Insightsright
More news about Godavari Drugs
11Feb 26
Godavari Drugs Reports Q3FY26 Results, Approves ₹5.50 Crore Working Capital Loan
Godavari Drugs reported Q3FY26 net profit of ₹75.76 lakhs on revenue of ₹2218.43 lakhs, showing decline from previous year's ₹76.74 lakhs profit and ₹2955.21 lakhs revenue. Nine-month performance also declined with net profit at ₹279.84 lakhs versus ₹348.69 lakhs last year. The Board approved a ₹5.50 crore short-term working capital loan from ICICI Bank with 6-month tenure for new order execution requirements.
 no imag found
15Jan 26
Godavari Drugs Board Approves Preferential Issue of Convertible Warrants and Equity Shares Worth ₹44.12 Crores
Godavari Drugs Limited board approved preferential issue of 23,60,065 convertible warrants and 25,96,935 equity shares at ₹89 each, raising approximately ₹44.12 crores. The warrants are exclusively for 9 promoters with 18-month conversion period, while equity shares target 31 investors including promoters and non-promoters. Post-allotment shareholding will be 51.52% promoters and 48.48% public, subject to shareholder approval in EGM scheduled February 12, 2026.
 no imag found
08Jan 26
Godavari Drugs Limited Issues Clarification on Share Price Movement to BSE
Godavari Drugs Limited submitted a clarification to BSE on January 8, 2026, regarding significant share price movement, confirming no unpublished price sensitive information exists. The company attributed the price volatility to market-driven demand-supply factors and reaffirmed its commitment to regulatory compliance under SEBI regulations.
 no imag found
Godavari Drugs
121.00
-1.90
(-1.55%)
1 Year Returns:+37.03%
Industry Peers
Sun Pharmaceutical
1,951.30
(+0.45%)
Divis Laboratories
7,277.00
(+1.23%)
Torrent Pharmaceuticals
5,010.80
(+0.75%)
Zydus Life Science
1,159.50
(+2.28%)
Cipla
1,438.50
(+0.03%)
Lupin
2,496.30
(+1.10%)
Mankind Pharma
2,581.00
(+1.97%)
Dr Reddys Laboratories
1,231.20
(-1.20%)
Aurobindo Pharma
1,552.90
(+0.01%)
Laurus Labs
1,556.30
(-0.28%)